ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how our rules link it today.

3 links0 made here, not in the record4 judgments1 judge (our rules as one)1 record change seen
Our rulesRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06283719Dose Escalation Study ofZG006 in Participants WithAdvanced Small Cell LungCancer or NeuroendocrineCarcinoma, Followed by DoseExpansion Study inParticipants With AdvancedSuzhou Zelgen BiopharmaceuticaPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 19 · ClinicalTrials.gov record · Version of 2026-10-19Version of 2026-10-19CONDITIONSSmall Cell Lung CarcinomaThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionCarcinoma, NeuroendocrineThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termFinest filed termDRUGSAlveltamigEntry “ZG006”, read by our name rule›As of now · Our role rule · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Small Cell Lung Carcinoma

From the registry record2 judgments on this link
Kind of condition link, from the registry to what was judged
RegistrySmall Cell Lung Carcinoma, as filedthe registry files the study under it
→judged
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Oct 19The record itselfClinicalTrials.gov recordVersion of 2026-10-19Record change
Nov 14Small Cell Lung CarcinomaOur condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, NeuroendocrineOur condition-kind ruleFinest filed termCurrent
As of nowSmall Cell Lung CarcinomaOur main-condition rule (R9)Main conditionCurrent
As of nowAlveltamigOur role ruleTestedCurrent